Lyell Immunopharma, Inc. (LYEL) — Dilution Risk Analysis
Current Snapshot
Lyell Immunopharma, Inc. (LYEL) has a DilutionWatch score of 61/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 61/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: FORM 4 2, EFFECT 1, S-3 1, 3 1, 4 5.
| Form | Filed | Accession |
|---|---|---|
| Form 4 | 2026-07-27 | 0001140361-26-029817|0002095697|2026-07-27|J|44000 |
| Form 4 | 2026-07-27 | 0001140361-26-029791|0002095697|2026-07-27|J|38500 |
| EFFECT | 2026-04-14 | 9999999995-26-001185 |
| S-3 | 2026-04-03 | 0001193125-26-142213 |
| 3 | 2026-03-16 | 0001808821-26-000005 |
| 4 | 2026-03-16 | 0001808821-26-000006 |
| 4 | 2026-03-09 | 0001012975-26-000234 |
| 4 | 2026-03-09 | 0001012975-26-000235 |
| 4 | 2026-02-12 | 0001907345-26-000002 |
| 4 | 2026-02-12 | 0001866154-26-000002 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 13 months | Source |
| Three-year share count growth | 45.94% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 61/10) Source
- Cash Runway
- 13 months Source
- Share Count Growth (3-Year)
- 45.94% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.